IVERIC bio Announces Fast Track Designation from U.S. FDA for Zimura® for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
NEW YORK--(BUSINESS WIRE)--IVERIC bio announced that the U.S. FDA has granted Fast Track designation to Zimura® for the treatment of geographic atrophy secondary to wet AMD.